Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Gamucci
WARNING LETTER
•Gamucci

Gamucci – FDA Warning Letter

Record Details

On September 8, 2010, the FDA issued a Warning Letter to Gamucci America, owned by Smokey Bayou, Inc., regarding their "Gamucci" electronic cigarette and cigar products. The FDA's review of the products' labeling and website (www.gamucci-america.com) indicated they are marketed as aids to quit smoking, healthier alternatives to traditional cigarettes, and safe nicotine delivery systems.

The FDA determined that these claims classify Gamucci products as unapproved new drugs and misbranded under the Federal Food, Drug, and Cosmetic Act. Specifically, the products are considered "new drugs" under section 201(p) and 505 of the Act (21 U.S.C. § 321(p), § 355) because they are promoted as smoking deterrents and for affecting body structure/function, yet lack adequate data for general recognition of safety and effectiveness. They are also misbranded under section 502 (21 U.S.C. § 352) for not having an approved new drug application and for lacking adequate directions for their intended drug uses, including smoking deterrence.

Gamucci America was required to respond within fifteen working days, detailing corrective actions, steps to prevent recurrence, and plans for already distributed products. Failure to comply could result in legal action, including seizure and injunction. The FDA also enclosed a letter to the Electronic Cigarette Association (E

Company
Gamucci
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Michael M. Levy
View Company Profile

ID · bc61eff3-0323-4056-939b-2aa8ecb2d8ec

Violation Codes9
21 U.S.C. 321(g)21 U.S.C. 35521 U.S.C. 35221 U.S.C. 321(h)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 CFR 201.12821 CFR 310.54421 CFR 201.5

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gamucci
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.